Hysterectomy test revealed Coventry woman’s rare cancer

by | Nov 19, 2026 | Health

Hysterectomy test revealed Coventry woman's rare cancer

Donna Marklew, an occupational therapist from Coventry, received a diagnosis of neuroendocrine cancer after undergoing a hysterectomy at Warwick Hospital to address complications from childbirth. The cancer was identified through analysis of tissue removed during the procedure, which had been performed to treat a uterine prolapse.

Neuroendocrine cancer is a rare condition affecting hormone-producing cells throughout the body. According to Neuroendocrine Cancer UK, the condition is estimated to impact approximately 6,000 people in the UK annually. The charity’s chief executive noted that patients typically experience a significant diagnostic delay, with an average of five years passing between first symptoms and diagnosis. This lag occurs because neuroendocrine cancer symptoms often resemble other medical conditions, causing patients to pursue alternative treatment paths before the true diagnosis becomes apparent.

Following her diagnosis, scans revealed tumours in Marklew’s appendix, Fallopian tubes, and surrounding tissue. In March 2025, she underwent a nine-hour surgical procedure at Warwick Hospital to remove as many tumours as possible. Beyond surgery, her treatment regimen includes three injections administered weekly and Peptide Receptor Radionuclide Therapy administered four times weekly every two months. She described her tumours as slow-growing grade two cancers, though they continue to progress.

Marklew has become an advocate for raising awareness about the disease, particularly in advance of World Neuroendocrine Cancer Day. She highlighted that the condition presents unique diagnostic challenges, especially for women. Prior to her hysterectomy, she had no identifiable symptoms, though she retrospectively attributed anxiety and palpitations during an earlier trip to Scotland as potential indicators, an interpretation her doctor had dismissed as perimenopausal. Despite the ongoing treatment demands, Marklew maintains a relatively normal life but has experienced significant psychological impacts from the diagnosis. She has established a patient support group and emphasized the value of resources provided by Neuroendocrine Cancer UK.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI